Data-Driven Discovery Research at 23andMe | GenomeWeb

In the July 2010 issue of Wired, on newsstands now, Thomas Goetz details Google co-founder Sergey Brin's investments in Parkinson's disease research. Brin, whose wife Ann Wojcicki co-founded the DTC genetic testing firm 23andMe, is pouring money into a data-driven approach to find the causes of — and potential cures for — the neurodegenerative disease that affects his mother, and that he has learned he carries a genetic disposition for.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.